Quattro Financial Advisors »

Akero Therapeutics shares owned by Quattro Financial Advisors

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Quattro Financial Advisors from 13F filings

Historical chart of Quattro Financial Advisors investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Quattro Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Quattro Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $295k 30 9843.33
2024-06-30 $469k 20k 23.46
2024-03-31 $253k 10k 25.26
2023-12-31 $234k 23 10152.17

More positions owned by Quattro Financial Advisors

Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
salesforce (CRM)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl A (GOOGL)
Emerson Electric (EMR)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Astrazeneca Sponsored Adr (AZN)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Core S&p Scp Etf (IJR)

View all positions for Quattro Financial Advisors

Top funds holding Akero Therapeutics

Henderson Group
BlackRock
BlackRock
General Atlantic
T. Rowe Price Associates
Vanguard Group
State Street Corporation
Alliancebernstein
Perceptive Advisors
Boxer Capital
Geode Capital Management
Redmile Group
Point72 Asset Management
T. Rowe Price Investment Management
Baker Bros. Advisors

View all funds holding Akero Therapeutics